We are live on ! Find out more
VNDA icon

Vanda Pharmaceuticals
VNDA

88 hedge funds and large institutions have $187M invested in Vanda Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 88 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

296% more call options, than puts

Call options by funds: $15.4M | Put options by funds: $3.89M

Holders
88
Holders Change
+88
Holders Change %
–
% of All Funds
2.87%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
88
Increased
–
Reduced
–
Closed
–
Calls
$15.4M
Puts
$3.89M
Net Calls
+$11.5M
Net Calls Change
+$11.5M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$32M +$26.7M +3,966,179 New
PAI
2
Palo Alto Investors
California
$19.2M +$16M +2,381,876 New
CCM
3
Consonance Capital Management
New York
$11.6M +$9.63M +1,429,798 New
Invesco
4
Invesco
Georgia
$9.11M +$7.59M +1,126,888 New
First Eagle Investment Management
5
First Eagle Investment Management
New York
$7.88M +$6.57M +975,000 New
BIM
6
Bogle Investment Management
Massachusetts
$7.85M +$6.55M +971,983 New
BFA
7
BlackRock Fund Advisors
California
$7.83M +$6.52M +968,501 New
BIT
8
BlackRock Institutional Trust
California
$7.37M +$6.14M +912,374 New
Fidelity Investments
9
Fidelity Investments
Massachusetts
$6.91M +$5.76M +855,354 New
VM
10
VHCP Management
New York
$6.36M +$5.3M +787,459 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$6.34M +$5.28M +784,271 New
NI
12
Numeric Investors
Massachusetts
$6.18M +$5.15M +764,547 New
Millennium Management
13
Millennium Management
New York
$4.43M +$3.7M +548,898 New
State Street
14
State Street
Massachusetts
$4.13M +$3.44M +510,518 New
TCIM
15
TIAA CREF Investment Management
New York
$3.88M +$3.24M +480,429 New
KCM
16
Kingdon Capital Management
New York
$3.59M +$3M +445,850 New
Northern Trust
17
Northern Trust
Illinois
$3.23M +$2.69M +399,180 New
Renaissance Technologies
18
Renaissance Technologies
New York
$2.86M +$2.38M +354,129 New
Deutsche Bank
19
Deutsche Bank
Germany
$2.55M +$2.13M +315,816 New
EI
20
EAM Investors
California
$2.14M +$1.78M +265,012 New
BCM
21
Bridgeway Capital Management
Texas
$2.01M +$1.68M +249,100 New
Bank of America
22
Bank of America
North Carolina
$1.94M +$1.62M +240,191 New
Two Sigma Investments
23
Two Sigma Investments
New York
$1.49M +$1.24M +184,290 New
Geode Capital Management
24
Geode Capital Management
Massachusetts
$1.4M +$1.16M +172,703 New
JGC
25
J. Goldman & Co
New York
$1.35M +$1.12M +167,000 New
1
2 3 4

VNDA Hedge Fund Activity: Q2 2013 in Review

88 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Vanda Pharmaceuticals (VNDA) for Q2 2013, worth a combined $187M.

Buyers outnumbered sellers: 88 funds opened new VNDA positions and 0 closed out — a net gain of 88 holders — while 0 added to existing stakes and 0 trimmed.

  • 88 institutional investors held Vanda Pharmaceuticals (VNDA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $187M of Vanda Pharmaceuticals stock for Q2 2013.
  • 88 funds opened new Vanda Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +88 holders.

Based on aggregated 13F filings for Q2 2013.